dehydroftorafur: Clinical Trials

5 trials of dehydroftorafur, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Terminated 5

Follow dehydroftorafur: new trials by email Literature Review of dehydroftorafur trials Research Report on dehydroftorafur

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin
Fluorouracil, Leucovorin, Liposomal Irinotecan - Locally Advanced Digestive System Neuroendocrine Carcinoma, Locally Advanced Pancreatic Neuroendocrine Carcinoma
Phase 2TerminatedRoswell Park Cancer Institute112019-06-172025-01-30
FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer
Fluorouracil, Irinotecan Hydrochloride, Laboratory Biomarker Analysis - Recurrent Colorectal Carcinoma, Stage IVA Colorectal Cancer
Phase 2TerminatedCity of Hope Medical Center12016-02-162018-08-16
Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer
Fluorouracil, Gemcitabine Hydrochloride, Intensity-Modulated Radiation Therapy - Pancreatic Adenocarcinoma, Stage IIA Pancreatic Cancer
Phase 2TerminatedAlbert Einstein College of Medicine232012-01-272023-12-05
Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer
Fluorouracil, Laboratory Biomarker Analysis, Leucovorin Calcium - Adenocarcinoma of the Gastroesophageal Junction, Esophageal Adenocarcinoma
Phase 2TerminatedUniversity of Nebraska112011-02-282023-10-26
Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer
Carboplatin, Chemoradiotherapy, Cisplatin - Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma
Phase 2TerminatedM.D. Anderson Cancer Center312008-06-162026-07-17

Conditions studied

Adenocarcinoma Of Esophagus (1)  ·  Colorectal Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Paranasal Sinus Neoplasms (1)  ·  Sinonasal undifferentiated carcinoma (1)  ·  Somatostatinoma (1)

Sponsors

Albert Einstein College of Medicine (1)  ·  City of Hope Medical Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  Roswell Park Cancer Institute (1)  ·  University of Nebraska (1)

Countries

United States (5)

Top investigators

Ehab Y Hanna (1)  ·  Jean L Grem, MD (1)  ·  Jennifer Chuy (1)  ·  Marwan Fakih (1)  ·  Renuka Iyer (1)

Results publications

PMID 33835977, PMID 36221952

NIH funding

P30CA013330 (1), P30CA036727 (1)